Global Pharmaceutical News

UK MHRA approves AbbVie’s migraine prevention drug Aquipta. [Quantung Pharma – Quantung.com]

European PFAS ban would burden drug companies and packagers. [Quantung Pharma – Quantung.com]

Germany’s environment and agriculture ministries are reportedly working on restrictions for biofuel production so more grain can be used as

Pharma industry: Proposed ‘forever chemicals’ ban would stifle innovation, access to drugs

The European Commission and international health agencies are closely monitoring a growing incidence of avian influenza in mammals.

EU chemical and pharmaceutical trade: robust growth. [Quantung Pharma – Quantung.com]

Biden administration to provide free Covid vaccines to uninsured Americans this fall through end of 2024

UnitedHealth stock jumps after earnings top estimates despite rising medical costs

A Degree in Health Science Could Be Just What the Doctor Ordered

The FDA has placed a clinical hold on Hemogenyx Pharmaceuticals’ investigational HEMO-CAR-T, which is being trialed for the treatment of acu

Amid declining demand for COVID-19 vaccines, embattled biotech Novavax is revising its advanced purchase contract with Canada’s department o

Friday, BrainStorm Cell Therapeutics posted positive Phase III data for its amyotrophic lateral sclerosis candidate NurOwn, showing that the

angioedema patients treated with Intellia’s NTLA-2002—an in vivo CRISPR-Cas9 therapy— had an average 95% reduction in the sudden, debilitati

The therapy becomes an option for moderate-to-severe plaque psoriasis in certain adults

Pioneer Group has announced a partnership with King’s College London to launch new dedicated start-up incubators in biotech and medtech on t

Chinese biotech BeiGene has acquired an exclusive license of an investigational antibody-drug conjugate for $1.3 billion from Shanghai-based

A project involving researchers based in Edinburgh wants to establish effective combinations of existing drugs which, used together, could t

GLORIA trial shows increased survival levels among newly diagnosed brain cancer patients TME Pharma – a company concentrating on the develo

Project aims to boost the adoption of technology across London’s NHS and help patients manage conditions

PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis